| Literature DB >> 28518031 |
Kenji Kondo, Takeshi Tsugawa, Mayumi Ono, Toshio Ohara, Shinsuke Fujibayashi, Yasuo Tahara, Noriaki Kubo, Shuji Nakata, Yoshihito Higashidate, Yoshiki Fujii, Kazuhiko Katayama, Yuko Yoto, Hiroyuki Tsutsumi.
Abstract
During March-July 2014, rotavirus G8P[8] emerged as the predominant cause of rotavirus gastroenteritis among children in Hokkaido Prefecture, Japan. Clinical characteristics were similar for infections caused by G8 and non-G8 strains. Sequence and phylogenetic analyses suggest the strains were generated by multiple reassortment events between DS-1-like P[8] strains and bovine strains from Asia.Entities:
Keywords: Asia; G8P[8] rotavirus strains; Japan; clinical features; enteric infections; epidemic; genotype; molecular characterization; outbreak; rotavirus; vaccines; viruses
Mesh:
Substances:
Year: 2017 PMID: 28518031 PMCID: PMC5443423 DOI: 10.3201/eid2306.160038
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Figure 1Distribution of rotavirus samples and their G/P genotypes in Hokkaido Prefecture (center map), Japan, 2014. The 4 locations from which the fecal samples were collected are shown on the map. Four hospitals (Tomakomai City Hospital, Japanese Red Cross Urakawa Hospital, Steel Memorial Muroran Hospital, and Sapporo Hokushin Hospital), and 2 clinics (Nakata Pediatric Clinic [Sapporo] and Tomakomai Children's Clinic) participated in the study. Map at left shows location of Hokkaido in Japan (gray shading).
Characteristics of patients infected with (G8P[8] and non-G8P[8] rotavirus, Tomakomai, Hokkaido Prefecture, Japan, 2014
| Patient characteristic | Patients infected with rotavirus | p value* | |
|---|---|---|---|
| G8P[8], n = 42 | Non-G8P[8], n = 42 | ||
| Sex, no. | 1.0 | ||
| M | 24 | 24 | |
| F | 18 | 18 |
|
| Median age, y | 1.8 | 2.0 | 0.50 |
| Vaccinated, no (%) | 2 (4.8) | 1 (2.4) | 0.56 |
| Clinical symptoms, mean ± SD | |||
| Duration of fever, d | 1.3 ± 1.2 | 1.7 ± 1.4 | 0.13 |
| Duration of diarrhea, d | 2.4 ± 1.6 | 2.5 ± 3.2 | 0.51 |
| Diarrhea episode in 24 h, maximum no. | 3.6 ± 3.2 | 4.3 ± 4.2 | 0.69 |
| Duration of vomiting, d | 1.4 ± 1.2 | 1.8 ± 2.9 | 0.79 |
| Vomiting episodes in 24 h, maximum no. | 3.6 ± 3.8 | 3.7 ± 3.5 | 0.98 |
| Admitted to hospital, no. (%) | 18 (42.9%) | 16 (38.1%) | 0.66 |
*Categorical data were analyzed by using χ2 tests; continuous data were analyzed by using Student’s t-tests or Mann-Whitney U tests.
Genotype constellations and nucleotide identities of strains closely related to To14-0, the representative G8P[8] rotavirus strain used in a study of the clinical and molecular features of a G8P[8] rotavirus outbreak strain, Hokkaido Prefecture, Japan, 2014
| Strain (genotype representative from study/country) | Genotype constellations and nucleotide identities (%), by gene* | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VP7 | VP4 | VP6 | VP1 | VP2 | VP3 | NSP1 | NSP2 | NSP3 | NSP4 | NSP5 | |
| Human/To14-0 (G8P[8] in study) | G8 ( | P[8] ( | I2 ( | R2 ( | C2 ( | M2 ( | A2 ( | N2 ( | T2 ( | E2 ( | H2 ( |
| Human/VNM/RVN1149/2014/G8P[8] (G8P[8] in Vietnam) | G8 ( | P[8] ( | I2 ( | R2 ( | C2 ( | M2 ( | A2 ( | N2 ( | T2 ( | E2 ( | H2 ( |
| Human/THA/NP-130/2014/G8P[8] (G8P[8] in Thailand) | G8 ( | P[8] ( | I2 ( | R2 ( | C2 ( | M2 ( | A2 ( | N2 ( | T2 ( | E2 ( | H2 ( |
| Human/THA/KKL-17/2013/G8P[8] (G8P[8] in Thailand) | G8 ( | P[8] ( | I2 (91.5) | R2 ( | C2 ( | M2 ( | A2 ( | N2 ( | T2 ( | E2 ( | H2 ( |
| Human/THA/LS-04/2013/G2P[8]
(DS-1–like G2P[8] in Thailand) | G2
(–) | P[8] ( | I2 ( | R2 (86.0) | C2 ( | M2 (97.4) | A2 ( | N2 ( | T2 (98.6) | E2 (95.5) | H2 ( |
| Human/THA/SKT-109/2013/G1P[8] (DS-1–like G1P[8] in Thailand) | G1
(–) | P[8] ( | I2 ( | R2 (86.1) | C2 ( | M2 ( | A2 ( | N2 (85.8) | T2 ( | E2 (94.5) | H2 ( |
| Human/To14-41 (DS-1–like G1P[8] in study) | G1
(–) | P[8] (98.8) | I2 (98.3) | R2 (86.3) | C2 ( | M2 ( | A2 ( | N2 (85.5) | T2 ( | E2 (93.5) | H2 (98.8) |
| Human/JPN/NT004/2012/G1P[8]
(DS-1–like G1P[8] in Japan) | G1
(–) | P[8] ( | I2 (98.4) | R2 (86.3) | C2 ( | M2 ( | A2 ( | N2 (85.6) | T2 ( | E2 (94.5) | H2 ( |
| Human/THA/NP-M51/2013/G2P[4] (G2P[4] in Thailand) | G2
(–) | P[4]
(–) | I2 ( | R2 (86.0) | C2 ( | M2 (97.5) | A2 ( | N2 (85.4) | T2 (98.7) | E2 (95.5) | H2 ( |
| Human/KOR/CAU15–11/2015/G2P[4] (G2P[4] in South Korea) | G2
(–) | P[4]
(–) | I2 ( | R2 (85.9) | C2 ( | M2 (97.4) | A2 (94.0) | N2 (84.8) | T2 (98.1) | E2 (95.3) | H2 (98.6) |
| Human/MU14114 (G2P[4] in study) | G2
(–) | P[4]
(–) | I2 (97.0) | R2 (85.3) | C2 (96.9) | M2 (86.4) | A2 (95.8) | N2 (85.5) | T2 (96.7) | E2 (95.6) | H2 (98.3) |
| Human/ITA/PR457/2009/G10P[14] | G10
(–) | P[14]
(–) | I2 (93.0) | R2 (98.1) | C2 (82.3) | M2 (86.6) | A11
(–) | N2 (86.4) | T6
(–) | E2 (94.3) | H3
(–) |
| Caprine/BGL/GO34/1999/G6P[1] | G6
(–) | P[1]
(–) | I2 (94.9) | R2 (86.3) | C2 (83.4) | M2 (86.8) | A11
(–) | N2 (86.6) | T6
(–) | E2 (96.0) | H3
(–) |
| Human/COD/DRC88/2003/G8P[8] (G8P[8] in Africa) | G8 (86.0) | P[8] (98.3) | I2 (96.3) | R2 (85.6) | C2 (97.4) | M2 (97.0) | A2 (96.4) | N2 (85.8) | T2 (97.1) | E2 (90.1) | H2 (97.4) |
| Human/MWI/QEC287/2006/G8P[8] (G8P[8] in Africa) | G8 (85.5) | P[8] (98.3) | I2 (96.3) | R2 (85.6) | C2 (97.8) | M2 (96.0) | A2 (96.5) | N2 (86.9) | T2 (96.6) | E2 (89.2) | H2 (97.6) |
| Human/MWI/QEC289/2006/G8P[8] (G8P[8] in Africa) | G8 (85.5) | P[8] (97.5) | I2 (96.3) | R2 (85.5) | C2 (97.8) | M2 (95.9) | A2 (96.5) | N2 (86.9) | T2 (96.6) | E2 (89.2) | H2 (97.6) |
*Purple indicates G8 genotype; green indicates Wa-like genome segments; red indicates DS-1–like genome segments; bold indicates nucleotide identities >99.0%; – indicates percentages not calculated because the genotype was different that for To14-0.
Figure 2Phylogenetic analysis of the viral protein 7 gene of G8 rotavirus strains used in a study of the clinical and molecular features of a G8P[8] rotavirus outbreak strain, Hokkaido Prefecture, Japan, 2014. Closed circle indicates the G8P[8] rotavirus strain from Hokkaido; open circles indicate human G8P[8] strains from Southeast Asia; and closed boxes indicate other strains from Japan. A Tamura 3-parameter model was used for the maximum-likelihood method. Bootstrap values are shown at the branch nodes (values of <80% are not shown). Scale bar indicates nucleotide substitutions per site.